Company:  AGENUS INC (AGEN)
Form Type:  4
Filing Date:  3/20/2017 
CIK:  0001098972 
Address:  3 FORBES ROAD 
City, State, Zip:  LEXINGTON, Massachusetts 02421 
Telephone:  781-674-4410 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.57  
Change: 
-0.03 (-0.83%)  
Trade Time: 
Apr 25  
Market Cap: 
$366.13M
Trade AGEN now with 

© 2018  
Description of Business
We are a clinical-stage immuno-oncology ("I-O") company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. Our business is designed to drive success in I-O through speed, innovation, and effective combination therapies. We have assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice ("GMP") manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. We leverage our immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance our innovation.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES